Katja Kivinen

Name:	Katja Kivinen
Affiliation:	Cardiovascular Medicine
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	Thu Jun 06 06:48:27 +0000 2019

Public lists managed by Katja Kivinen

Talks given by Katja Kivinen

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by Katja Kivinen

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Katja Kivinen actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Vascular aging (tbc)
• Pathology, pragmatic trials and population health data science to prevent vascular ageing
• RyR2 Calcium Release Channels in Cardiac Arrhythmia - Deciphering Mechanisms and Controversies.
• UK Biobank and cardiovascular magnetic resonance: opportunities and challenges
• Hypertension, Left Ventricular Remodelling and Heart Failure in Black Africans
• TBC
• British Science Association Media Fellowship - the inside scoop on how science gets reported at The Guardian
• Delivering integrated care
• Novel mechanisms that induce or control IL-1-driven inflammation and immune dysfunction
• Most cardiovascular risk prediction equations need to be updated or replaced
• Novel Mechanisms of Dysregulated Endothelium in Pulmonary Arterial Hypertension
• BHF Alumni Programme overview
• The Swedish model for CVD prevention: Public Health cultivation combined with individual health dialogues in Primary Care
• New insights into clinical implications of cardiovascular ageing
• Interpretation of large-scale randomised evidence
• Challenges and opportunities for research and better practice in hospital
• Epidemiology of High Blood Pressure
• Using three-dimensional chromatin structure to understand autoimmune disease mechanisms
• Reactivating developmental mechanisms to regenerate the heart
• TBC - Prof Albert Sickmann
• Extracellular vesicles at the cross-line between basic science and clinical translation?
• Highlights from the 2016 European Guidelines of CVD prevention: What is new?
• Vascular disease modelling using iPS: new insights into Marfan Syndrome
• Novel assays shows that coronary artery disease patients have heightened procoagulant potential and implicates the Cyclophilin D dependent necrosis pathway
• Cardiac arrhythmias - genetics, metabolism and mechanisms
• Targeting Protease Signaling in Atherothrombosis and NASH with Cell-Penetrating Pepducins
• New mechanisms of inflammasome activation
• Atria-specific upregulation of microRNA-31 depletes dystrophin and neuronal nitric oxide synthase (nNOS), and leads to electrical remodelling in human atrial fibrillation
• Ice Templated Structures for Regenerative Medicine
• Public Engagement and social media
• Profiling the signalling networks in blood platelets by multiparameter flow cytometry
• New trends in cardiac valve and cardiovascular modelling
• Novel mechanisms connecting innate immunity, microbiota and lipid metabolism: potential therapeutic approaches for atherosclerosis?
• Strategies for improving the biocompatibility of vascular medical devices by xNA-based surface modifications
• Mechanisms of danger sensing by the NLRP3 inflammasome
• Epidemiological perspectives on the cardiovascular disease epidemic
• Should we include the family in preventive cardiology initiatives?
• Exploiting B cells and humoral immunity to treat atherosclerosis and hepatic inflammation
• Making PCI safer, insights from NICOR
• The role of the cytoskeleton in platelet production and the pathogenesis of platelet disorders in humans and mice
• Which is the role of myocardial trabeculae?
• TBC
• Mobile elements, polydactyl proteins and the species-specificity of human biology
• Understanding Cellular Heterogeneity
• Living without oxygen: Lessons from cold-blooded vertebrates
• Novel Regulatory Mechanisms of Bone Marrow Homeostasis
• Novel Regulation of the Pulmonary Endothelium
• The Missing LINC in Cardiomyopathy
• The role of zinc as a physiologically relevant platelet agonist
• HIFs, mitochondria and cardioprotection
• Are all inequalities in heart disease unfair?
• Regulating haemogenic and angiogenic sprouting from the dorsal aorta
• Bridging the gaps in translational medicine
• Designing drugs at the 5HT1B serotonin receptor: from Migraine to Pulmonary Hypertension
• TBC (single-cell sequencing/transcriptomics)
• Imaging metabolism using hyperpolarized 13C-labelled cell substrates
• Genetic and epigenetic alterations in patients with congenital heart disease
• Are Haemostasis and Thrombus Formation Regulated by Platelet Subpopulations? (Focus on Nitric Oxide Signalling)
• Heart Disease Link to Developmental Hypoxia and Oxidative Stress
• Cardiac expression of Cyclooxigenase-2 limits the ischemic-reperfusion injury
• Caveolae protect endothelial cells from rupture during increased cardiac output
• Screening and treatment for abdominal aortic aneurysms - what is the evidence?
• Platelet death signalling in thrombosis and thrombocytopenia
• Epigenetic control of cardiac hypertrophy
• Atherosclerosis Imaging: from MRI, VH-IVUS to Biomechanical Analysis - Looking beyond luminal stenosis
• Symplectic/Altmetric - New features
• Mechanical factors underlying aortic stiffness, aneurysms and dissections
• Cardiovascular Development: Insights into Regeneration
• Targeting the carotid body for controlling hypertension in rat and human
• CADASIL - an affair between Notch3 receptor and the extracellular matrix
• Update in Regenerative Medicine Strategies for Lung Diseases and Critical Illnesses
• CANCELLED
• Regulation of inflammation, lipids and atherosclerosis by tribbles